The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #4 is a biotech by the name of Cardiff Oncology (CRDF). The reason why I wanted to go over this ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...
India must lead in biotech sovereignty powered by AI. This convergence will shape healthcare, food, and biosecurity. Nations controlling biology and AI will define the future. India needs to develop ...